Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

323 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A, Cirioni O, Ghiselli R, Orlando F, Mocchegiani F, Riva A, Del Prete MS, Saba V, Scalise G. Giacometti A, et al. Among authors: scalise g. Antimicrob Agents Chemother. 2002 Sep;46(9):2885-8. doi: 10.1128/AAC.46.9.2885-2888.2002. Antimicrob Agents Chemother. 2002. PMID: 12183242 Free PMC article.
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O, Giacometti A, Ghiselli R, Dell'Acqua G, Gov Y, Kamysz W, Lukasiak J, Mocchegiani F, Orlando F, D'Amato G, Balaban N, Saba V, Scalise G. Cirioni O, et al. Among authors: scalise g. Circulation. 2003 Aug 12;108(6):767-71. doi: 10.1161/01.CIR.0000083717.85060.16. Epub 2003 Jul 28. Circulation. 2003. PMID: 12885754
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A, Ghiselli R, Cirioni O, Mocchegiani F, Orlando F, Del Prete MS, D'Amato G, Silvestri C, Saba V, Scalise G. Giacometti A, et al. Among authors: scalise g. J Antimicrob Chemother. 2003 Oct;52(4):724-6. doi: 10.1093/jac/dkg396. Epub 2003 Sep 1. J Antimicrob Chemother. 2003. PMID: 12951347
A chimeric peptide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci.
Balaban N, Gov Y, Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, D'Amato G, Saba V, Scalise G, Bernes S, Mor A. Balaban N, et al. Among authors: scalise g. Antimicrob Agents Chemother. 2004 Jul;48(7):2544-50. doi: 10.1128/AAC.48.7.2544-2550.2004. Antimicrob Agents Chemother. 2004. PMID: 15215107 Free PMC article.
Temporin A soaking in combination with intraperitoneal linezolid prevents vascular graft infection in a subcutaneous rat pouch model of infection with Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Giacometti A, Cirioni O, Ghiselli R, Orlando F, D'Amato G, Kamysz W, Mocchegiani F, Sisti V, Silvestri C, Łukasiak J, Rocchi M, Saba V, Scalise G. Giacometti A, et al. Among authors: scalise g. Antimicrob Agents Chemother. 2004 Aug;48(8):3162-4. doi: 10.1128/AAC.48.8.3162-3164.2004. Antimicrob Agents Chemother. 2004. PMID: 15273140 Free PMC article.
323 results